跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
泰吉华 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Avapritinib Tablets
Approved
化学药品
Avapritinib Tablets
Blueprint Medicines
🇨🇳 National Medical Products Administration
Approval Date
Mar 30, 2021
Approval ID
887WQy6yfTO
Company
Blueprint Medicines
Type
化学药品
Approval Details
Approval Id
887WQy6yfTO
Approval Number
国药准字HJ20210019
Generic Name
阿伐替尼片
Generic Name En
Avapritinib Tablets
Trade Name
泰吉华
Drug Type
化学药品
Dosage Form
片剂
Strength
100mg
Reg Date
2021-03-30
Expired Date
2026-03-29
Company Name
Blueprint Medicines
Production Company Name
CATALENT NOTTINGHAM LIMITED
Company Detail Path
/organization/blueprint-medicines
Production Company Detail Path
/organization/catalent-nottingham-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 30, 2021
Approval ID
887WQy6yfTO
Type
化学药品
Back to NMPA Approvals